ArticleCancer research2025

Characterization of Drug-Tolerant Persister Cells in Triple-Negative Breast Cancer Identifies a Shared Persistence Program across Treatments and Patients.

Léa Baudre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.